Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables

H. Jo, R. Russo, M. Pearson, E. Veitch, M. Peters (Sydney, Australia)

Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Session: Idiopathic pulmonary fibrosis: clinical view
Session type: Poster Discussion
Number: 3372
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Jo, R. Russo, M. Pearson, E. Veitch, M. Peters (Sydney, Australia). Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables. Eur Respir J 2013; 42: Suppl. 57, 3372

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002



Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016

Analyses of the relationship between ΔFVC, extent of fibrosis and extent of emphysema in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF clinical
Year: 2016

Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2014 – ILDs 1
Year: 2014


Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Interstitial fibrosis with a nodule
Source: Annual Congress 2007 - Thoracic Oncology Grand Round: an interactive session
Year: 2007

Markers of pulmonary vascular compromise predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008


Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008



Novel CT markers of volume loss in idiopathic pulmonary fibrosis (IPF) predict mortality
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017



The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016

Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015


The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015


Lung cancer in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 1216-1219
Year: 2001



Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment
Source: International Congress 2016 – IPF treatment I
Year: 2016


Effect of baseline FVC on lung function decline with nintedanib in patients with IPF
Source: International Congress 2015 – Treatment of IPF
Year: 2015